About 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one
3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one (PubChem CID 122192028) has the molecular formula C21H20N2O3
and a molecular weight of 348.40 g/mol. Its IUPAC name is 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one.
Molecular Properties
| Compound Name | 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one |
| PubChem CID | 122192028 |
| Molecular Formula | C21H20N2O3 |
| Molecular Weight | 348.40 g/mol |
| Exact Mass | 348.15 |
| IUPAC Name | 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one |
| SMILES | CCCCn1ccnc1/C=C/C(=O)/C=C/c1coc2ccccc2c1=O |
| InChI | InChI=1S/C21H20N2O3/c1-2-3-13-23-14-12-22-20(23)11-10-17(24)9-8-16-15-26-19-7-5-4-6-18(19)21(16)25/h4-12,14-15H,2-3,13H2,1H3/b9-8+,11-10+ |
| InChIKey | RCQIYPZBRYLCBO-BNFZFUHLSA-N |
| XLogP | 4.09 |
| TPSA | 65.10 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 348.40 |
| LogP ≤ 5 | 4.09 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Analyze 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one?
The IUPAC name of 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one (CID 122192028) is 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one.
What is the SMILES notation for 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one?
The canonical SMILES for 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one is CCCCn1ccnc1/C=C/C(=O)/C=C/c1coc2ccccc2c1=O.
What is the InChIKey of 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one?
The InChIKey is RCQIYPZBRYLCBO-BNFZFUHLSA-N. The full InChI is InChI=1S/C21H20N2O3/c1-2-3-13-23-14-12-22-20(23)11-10-17(24)9-8-16-15-26-19-7-5-4-6-18(19)21(16)25/h4-12,14-15H,2-3,13H2,1H3/b9-8+,11-10+.
What are the key properties of 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one?
3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one has a molecular weight of 348.40 g/mol, XLogP of 4.09, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(1E,4E)-5-(1-butylimidazol-2-yl)-3-oxopenta-1,4-dienyl]chromen-4-one is sourced from PubChem (CID 122192028), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).